NEUROMAMA, LTD. Financial Statements (2025 and earlier)
Company Profile
Business Address |
182/1 KRASNIY PROSPEKT, SUITE # 704 NOVOSIBIRSK, 630049 |
State of Incorp. | NV |
Fiscal Year End | January 31 |
Industry (SIC) | 509 - Miscellaneous Durable Goods (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
1/31/2013 | |||
---|---|---|---|
ASSETS | |||
Current Assets | |||
Cash, cash equivalents, and short-term investments | |||
Cash and cash equivalents | |||
Other undisclosed current assets | |||
Total current assets: | |||
Noncurrent Assets | |||
TOTAL ASSETS: | |||
LIABILITIES AND EQUITY | |||
Liabilities | |||
Current Liabilities | |||
Other undisclosed current liabilities | |||
Total current liabilities: | |||
Noncurrent Liabilities | |||
Total liabilities: | |||
Equity | |||
Equity, attributable to parent, including: | |||
Common stock | |||
Additional paid in capital | |||
Other undisclosed equity, attributable to parent | |||
Total equity: | |||
TOTAL LIABILITIES AND EQUITY: |
Income Statement (P&L) (USD)
1/31/2013 | ||
---|---|---|
Operating expenses | ||
Other operating income, net (Other Expenses) | ||
Operating income: | ||
Income from continuing operations: | ||
Income before gain (loss) on sale of properties: | ||
Net income: | ||
Other undisclosed net loss attributable to parent | ||
Net loss available to common stockholders, diluted: |
Comprehensive Income (USD)
1/31/2013 | ||
---|---|---|
Net income: | ||
Comprehensive income, net of tax, attributable to parent: |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.